Immuneering Corp Stock Investor Sentiment

IMRX Stock  USD 2.09  0.04  1.88%   
Slightly above 62% of Immuneering Corp's investor base is looking to short. The analysis of overall sentiment of trading Immuneering Corp stock suggests that many investors are alarmed at this time. Immuneering Corp's investing sentiment can be driven by a variety of factors including economic data, Immuneering Corp's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at www.macroaxis.com         
Acquisition by Zeskind Benjamin J. of 20000 shares of Immuneering Corp at 2.7663 subject to Rule 16b...
Macroaxis News
over six months ago at seekingalpha.com         
Immuneering stock rebounds 34 percent following last weeks selloff
seekingalpha News
over six months ago at investing.com         
Cormorant Asset Management sells over 2.7 million in Immuneering Corp shares
Investing News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Feinberg Peter of 45024 shares of Immuneering Corp at 2.3067 subject to Rule 16b-3
Macroaxis News
over six months ago at benzinga.com         
Disposition of 400000 shares by Cormorant Asset Management, Lp of Immuneering Corp at 2.141 subject ...
benzinga news
over six months ago at benzinga.com         
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Tr...
benzinga news
over six months ago at simplywall.st         
Immuneering Corporations latest 57 percent decline adds to one-year losses, institutional investors ...
Simply Wall St News at Macroaxis
over six months ago at investing.com         
Immuneering stock target cut to 15 by Needham
Investing News at Macroaxis
over six months ago at investing.com         
Immuneering stock price target cut to 16 from 21
Investing News at Macroaxis
over six months ago at seekingalpha.com         
TD Cowen cuts Immuneering to market perform, cites Phase 1 data
seekingalpha News
over six months ago at benzinga.com         
Whats Going On With Cancer-Focused Immuneering Stock On Thursday?
benzinga news
over six months ago at finance.yahoo.com         
Disposition of 11040 shares by Cormorant Asset Management, Lp of Immuneering Corp at 5.968 subject t...
Yahoo News
over six months ago at benzinga.com         
Why Limbach Holdings Shares Are Trading Lower By Around 15 Here Are Other Stocks Moving In Thursdays...
benzinga news
over six months ago at seekingalpha.com         
Immuneering stock gain on data for cancer drug
seekingalpha News
over six months ago at finance.yahoo.com         
Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 12a Clinical Trial ...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Immuneering Corp that are available to investors today. That information is available publicly through Immuneering media outlets and privately through word of mouth or via Immuneering internal channels. However, regardless of the origin, that massive amount of Immuneering data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immuneering Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immuneering Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immuneering Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immuneering Corp alpha.

Immuneering Corp Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.